tirzepatide and duloxetine GLP-1 Drugs: New Reports of Dysesthesia and Allodynia Tirzepatide is a New Medication

This represents a huge population (in the US alone) for companies to consider as a lucrative opportunity for a type of drug that only 3-4 years ago was not even in the picture - for the treatment of overweight or obesity, which was burdened with a huge taboo

What was once accessible primarily through traditional insurance-based healthcare-often with significant out-of-pocket costs or coverage denials-is now available through innovative telehealth platforms that prioritize affordability and accessibility

However, my colleagues and I also found previously unidentified risks

PubMed Ng, F.M., Sun, J., Sharma, L., Libinaki, R., Jiang, W.J., & Gianello, R